Patent · US Active

Nanochanneled device and related methods

US9005185B2 · kind B2 · utility

1Cited by
22References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 6, 2013
Grant dateApr 14, 2015
Priority date
Expiry dateDec 6, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T156/1064
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A capsule configured for in vivo refilling of a therapeutic agent. In certain embodiments, the capsule may contain methotrexate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.